In an interview with BPI France<\/strong><\/a> in partnership with Les Echos<\/em>, our Chairman Pierre Gavignon<\/strong> shares the vision that has driven Steritech for over 30 years. In this article, we take a closer look at the export issue, which is at the heart of our DNA<\/a>, the challenges we face and the best practices to remember for any company wishing to enter the export market.<\/p>\n\n Since its creation, Steritech<\/strong> has made the strategic choice to focus its development on international markets. Why do we do this? Because the need for “International business is part of our DNA. For Steritech, exporting is not an option, but a matter of course.”<\/em> – Pierre Gavignon, Steritech Chairman<\/p>\n\n This approach has enabled us to establish ourselves in demanding markets<\/strong> such as Asia, South America and Western Europe. Each project is designed to meet the specific needs of local customers, while respecting international quality standards. <\/p>\n\n Today, 90% of our sales come from exports<\/strong>, with 46 countries conquered<\/strong> and solutions installed on every continent. This positioning reflects a strong conviction: French innovation must shine on the international stage<\/strong>, and Steritech is a perfect example of this. <\/p>\n\n